Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow-to-Debt Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2023, meaning its operating cash flow of €2.10 Billion could theoretically repay 0% of its total liabilities (€38.23 Billion) in one year. See Guangzhou Baiyunshan Pharmaceutical Hold free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 13 annual periods. Also explore GU5 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Year-by-year debt coverage analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For market capitalisation and broader financial context, see Guangzhou Baiyunshan Pharmaceutical Hold market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | €-232.46 Million | €44.43 Billion | ▼ -106.7% |
| 2024 | 0.08x | €3.44 Billion | €43.91 Billion | ▼ -19.9% |
| 2023 | 0.10x | €4.10 Billion | €41.91 Billion | ▼ -42.6% |
| 2022 | 0.17x | €7.00 Billion | €41.03 Billion | ▲ +4.6% |
| 2021 | 0.16x | €5.67 Billion | €34.79 Billion | ▲ +779.3% |
| 2020 | 0.02x | €585.19 Million | €31.55 Billion | ▼ -88.6% |
| 2019 | 0.16x | €5.02 Billion | €30.90 Billion | ▼ -11.7% |
| 2018 | 0.18x | €5.22 Billion | €28.34 Billion | ▼ -9.1% |
| 2017 | 0.20x | €1.83 Billion | €9.05 Billion | ▼ -34.4% |
| 2016 | 0.31x | €2.54 Billion | €8.24 Billion | ▲ +14.2% |
| 2015 | 0.27x | €1.94 Billion | €7.19 Billion | ▼ -1.9% |
| 2014 | 0.28x | €1.75 Billion | €6.34 Billion | ▲ +7.8% |
| 2013 | 0.26x | €1.34 Billion | €5.23 Billion | — |